About
Dr. Ponce is an Executive Vice President, Nonclinical Development at Shape Therapeutics, a gene therapy company focusing on RNA editing (Seattle, WA). Prior to this position he was Sr. Director, Nonclinical Development at Juno Therapeutics (Seattle, WA), Scientific Director, Comparative Biology and Safety Sciences at Amgen (Seattle, WA), and Director of Preclinical Safety Assessment at ZymoGenetics, Inc. (Seattle, Washington). He has previously worked as a research toxicologist at SNBL USA and the University of Washington, and as a toxicologist for the Alaska Department of Health and Social Services. Dr. Ponce is an Affiliate Associate Professor in the Department of Environmental and Occupational Health Sciences, University of Washington and is a Diplomate of the American Board of Toxicology.